Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.
about
Medulloblastoma stem cells: Promising targets in medulloblastoma therapyAdvances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumorsDifferential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potentialA microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesisContrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Rare childhood cancers--an increasing entity requiring the need for global consensus and collaboration.MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes.Drug discovery in paediatric oncology: roadblocks to progress.The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.Molecular Classification of Medulloblastoma.Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.The molecular landscape of pediatric brain tumors in the next-generation sequencing era.Molecular biology of pediatric brain tumors and impact on novel therapies.Evolving molecular era of childhood medulloblastoma: time to revisit therapy.Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation.BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.Demographics, patterns of care, and survival in pediatric medulloblastoma.Medulloblastoma initiation and spread: Where neurodevelopment, microenvironment and cancer cross pathways.Impact of tumor location and fourth ventricle infiltration in medulloblastoma.Therapeutic opportunities for medulloblastoma come of age.Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.Rapid determination of medulloblastoma subgroup affiliation with mass spectrometry using a handheld picosecond infrared laser desorption probe.A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.Our panel of experts highlights the most important research articles across the spectrum of topics relevant to the field of CNS oncology.
P2860
Q26750427-D321A679-FCF1-47B9-ABA9-E9CD97717255Q26866408-1EDB91B3-A5AC-48E9-84D3-C752C0E0DA45Q33618570-743A1CA6-FC85-4096-8CD3-3C437743343CQ34457533-83FE395C-9DF8-4C0B-B3E7-6D96C1E902ECQ35440212-42AC6232-0D1B-4FC0-8464-5E1042CCB333Q35630417-52DA3A42-497E-43AB-A249-C923ABF39065Q35754390-9EF76E5B-4458-411E-A7F9-8BC66FBEF1CCQ35755368-4A4FFE92-2D64-4C36-BC9B-18AEBA9E1F98Q35831225-EFFF40F4-DB7A-4E73-93C4-C057D599709CQ36262295-DDFFF7D2-A061-4D22-AE7D-160EDAE1CE9CQ36334648-417D5E72-FF3C-4AAC-AC18-6EA8F3677F97Q36901551-8388B292-68E7-4FC7-9F33-99DC72DC5AB1Q37022200-57B2433E-CE8D-4C8B-92E4-E57BDA031EB0Q37573700-ED4F1AC1-FAE0-4D9E-90EC-4DCBD5F8F9B0Q37615744-0BC73223-BEAB-43BD-AAE7-F64AFFECD72CQ37628299-C9CB8E20-AB5C-4E50-8393-9E0D1AE96B5AQ38231122-E530D39F-9867-42DD-BCA3-F630DB914877Q38359284-C4C3CA95-2497-4A6F-BE86-411D51C3FDF8Q38652681-1A8BC7E9-5307-4176-AB95-64637FD9BF5DQ38756270-6EBDBE49-078F-4D9E-ADED-89F8645E1DE7Q38816142-0804053D-D46E-4614-854F-C08E58CFB932Q38909956-2FCA87BC-4E21-4A44-89B6-61BC3D03AF3BQ38954656-E0E64093-FCB5-428F-83FD-535F4796A75AQ39828699-38E8A5D5-9D0C-47C2-B31C-693190EBBD22Q39976047-6C647E7B-9F80-4AD1-933D-097B8BCDA5FAQ40682183-8924E7B0-135F-4C24-9FBC-E144443B8807Q42045784-CA27280F-6A6C-47DD-BE9D-BA5BDBE93721Q52638234-632D02E9-76BF-4ACF-867C-60F1FB80705DQ52714457-1DEC837D-CA15-46F7-A78B-A06A1FCF9B3EQ55315698-A5DF175F-B0D1-465B-B9CF-BBA07CCFCFF6
P2860
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group.
@en
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group.
@nl
type
label
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group.
@en
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group.
@nl
prefLabel
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group.
@en
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group.
@nl
P2093
P2860
P50
P1476
Medulloblastoma Down Under 201 ...... Medulloblastoma Working Group
@en
P2093
Amar Gajjar
Barry Pizer
Brandon Wainwright
Catherine H Cole
Clinton F Stewart
Dan Williamson
David L Baker
David M Ashley
David W Ellison
Franck Bourdeaut
P2860
P2888
P304
P356
10.1007/S00401-013-1213-7
P50
P577
2013-11-22T00:00:00Z